Skip to main content

Table 1 Associations of KLK mRNA expression with clinical parameters in advanced high-grade serous ovarian cancer

From: Prognostic value of kallikrein-related peptidase 7 (KLK7) mRNA expression in advanced high-grade serous ovarian cancer

Clinical parameters

KLK7a

low/high

KLK5 + KLK7b

low/high

Age

p = 0.564

p = 0.141

≤ 60 years

40/18

26/32

> 60 years

56/25

46/34

Residual tumor mass

p = 0.234

p = 0.041

0 mm

51/19

43/27

> 0 mm

44/23

29/37

Ascites fluid volume

p = 0.261

p = 0.244

≤ 500 ml

54/24

45/32

> 500 ml

41/13

26/28

  1. a Chi-square test (cut-off point: KLK7 = 67th percentile)
  2. b Chi-square test (dichotomized into low level by KLK5 low and KLK7 low, and high level by KLK5 high and/or KLK7 high; cut-off point: KLK5 = 67th percentile, KLK7 = 67th percentile)
  3. Due to missing values, numbers do not always add up to n = 139.